Summaries of Allegations
Matters that will be proceeding before the Discipline Committee, and the hearing dates (if known).

Member

Summary of Allegations

Bennett, Andrew

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Bennett committed professional misconduct in that he failed to cancel unused and/or re-used doses; billed patient G.H. daily for Plavix 75mg from December 21, 2007 to April 27, 2008; billed patient C.B. daily for medications from March 24, 2008 to July 31, 2008; billed patient V.C. weekly for medications from February 11, 2008 to July 25, 2008, and again from August 29, 2008 to October 10, 2008; charged an individual dispensing fee for each of multiple doses of methadone dispensed to patients as carries in the absence of a methadone capitation agreement; charged an individual dispensing fee for each of 2 prescriptions of Gabapentin 300mg dispensed concurrently to G.B. from August 24, 2007 to November 20, 2007, pursuant to the transfer of only 1 prescription to the pharmacy; dispensed methadone doses to patients as carries without authorization; dispensed Rx# 1008996, 1008999 and 1009001 without authorization; failed to maintain records as required; reduced the quantity of methadone dispensed without authorization; dispensed drugs in weekly compliance pill packs in less than the full amount prescribed for patients without informed authorizations in writing from those patients; recorded 2 prescriptions of Gabapentin 300mg dispensed concurrently to G.B. from August 24, 2007 to November 20, 2007, pursuant to the transfer of only 1 prescription to the pharmacy; In particular, it is alleged that he: failed to maintain the standards of practice of the profession; failed to keep records as required respecting the member’s patients; falsified a record relating to the member’s practice; charged a fee that was excessive in relation to the service provided; contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular, sections 155 and/or 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-4, as amended; contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, section 9 of the Drug Interchangeability and Dispensing Fee Act, R.S.O. 1990, c. P.23; section 5 of O.Reg. 936 under the Drug Interchangeability and Dispensing Fee Act; sections 5, 6(2) and 15(a) and (b) of the Ontario Drug Benefit Act, R.S.O. 1990, c.O.10; subsections 18(7), 18(8), 18(9) and 18(10) of Ontario Regulation 201/96 under the Ontario Drug Benefit Act; and section 38 of the Narcotic Control Regulations, C.R.C., c.1041, as amended, under the Controlled Drugs and Substances Act, S.C. 1996, c. 19, as amended; engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional Hearing Date: TBA

Member

Summary of Allegations

Haditaghi, Majid

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Haditaghi committed professional misconduct in that he failed to maintain records as required improperly stored drugs failed to cancel unused and/or re-used doses dispensed reduced quantities without written authorization incompletely transcribed verbal authorizations In particular, it is alleged that he failed to maintain the standards of practice of the profession failed to keep records as required respecting his patients contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional Hearing Date: TBA

Member

Summary of Allegations

Hanif, Mohamed Imran

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Hanif committed professional misconduct in that he failed to maintain the professional boundaries of the pharmacist-patient relationship when he developed a non-professional, personal relationship with the patient, T.W., in or about July 2008 - November 2009 engaged in sexual abuse of the patient, T.W., on one or more occasions, in or about October - November 2009. In particular, it is alleged that he failed to maintain a standard of practice of the profession abused a patient, verbally or physically engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional Hearing Date: June 14, 15, 20 and 21, 2012

Member

Summary of Allegations

Hanna, Ashraf

It is alleged that Mr. Hanna committed acts of professional misconduct in that, while acting as shareholder, director, and/or pharmacist at Green Cross Pharmacy in Scarborough, Ontario, he: failed to maintain a standard of practice of the profession; failed to keep records as required respecting his patients; falsified a record relating to his practice; signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement; contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular, sections 155 and/or 156 of the Drug and Pharmacies Regulation Act , R.S.O. 1990, c. H-4, as amended, and/or section 76(3) of the Health Professions Procedural Code, being Schedule 2 to the Regulated Health Professions Act, 1991, S.O. 1991, c. 18, as amended; conttravened, while engaged in the practice of pharmacy, a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, section C.01.041 of the Food and Drug Regulations, C.R.C., c. 870, as amended, to the Food and Drugs Act, R.S.C. 1985, c.F-27, as amended; and/or engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional with respect to the following incidents: dispensing Fluphenazine Inj to the patient, T.K., on or about January 10, 2005 and/or February 4, 2005 when Fluanxol Depot 2% had been prescribed; failing to respond appropriately when the medication errors committed on or about January 10, 2005 and/or February 4, 2005 with respect to the patient, T.K., were identified on or about April 1-2, 2005, and subsequently; providing inaccurate or erroneous information to Dr. L. regarding the claimed interchangeability of Fluanxol Depot 2% and Fluphenazine Inj on or about April 1-2, 2005; failing to keep records as required respecting his patients regarding the prescription by Dr. L. dated January 5, 2005 for Fluanxol Depot 2% for the patient, T.K., and the pharmacy records related to that prescription; falsifying a prescription and pharmacy records in the attempt to conceal the medication errors committed on or about January 10, 2005 and/or February 4, 2005 with respect to the patient, T.K.; and/or withholding documents requested by a duly appointed investigator in or about July-August 2006, namely, the documents relating to the fax communication of the original prescription in Rx #023942 to the College of Physicians and Surgeons of Ontario. Hearing Date: April 18, 19 and 20, 2012; and May 2, 3 and 4, 2012

Member

Summary of Allegations

Ibrahim, Ihab

It is alleged that Mr. Ibrahim committed an act or acts of professional misconduct in that, while in that, while acting as shareholder, director, designated manager and/or pharmacist at Green Cross Pharmacy in Scarborough, Ontario, he: failed to maintain a standard of practice of the profession; failed to keep records as required respecting his patients; falsified a record relating to his practice with respect to a prescription and pharmacy records; signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement; contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular, sections 155 and/or 156 of the Drug and Pharmacies Regulation Act , R.S.O. 1990, c. H-4, as amended, and/or section 76(3) of the Health Professions Procedural Code, being Schedule 2 to the Regulated Health Professions Act, 1991, S.O. 1991, c. 18, as amended; contravened, while engaged in the practice of pharmacy, a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, section C.01.041 of the Food and Drug Regulations, C.R.C., c. 870, as amended, to the Food and Drugs Act, R.S.C. 1985, c.F-27, as amended; and/or, engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional, with respect to the following incidents: dispensing Fluphenazine Inj to the patient, T.K., on or about January 10, 2005 and/or February 4, 2005 when Fluanxol Depot 2% had been prescribed; failing to respond appropriately when the medication errors committed on or about January 10, 2005 and/or February 4, 2005 with respect to the patient, T.K., were identified on or about April 1-2, 2005, and subsequently; providing inaccurate or erroneous information to Dr. L. regarding the claimed interchangeability of Fluanxol Depot 2% and Fluphenazine Inj on or about April 1-2, 2005; failing to keep records as required respecting his patients regarding the prescription by Dr. L. dated January 5, 2005 for Fluanxol Depot 2% for the patient, T.K., and the pharmacy records related to that prescription; falsifying a prescription and pharmacy records in the attempt to conceal the medication errors committed on or about January 10, 2005 and/or February 4, 2005 with respect to the patient, T.K.; filing a complaint against Dr. L. with the College of Physicians and Surgeons of Ontario on or about May 2, 2005 to blame the medication errors and other inappropriate conduct on him when it was known that the medication errors had been committed at the pharmacy on or about January 10, 2005 and/or February 4, 2005 with respect to the patient, T.K.; and/or withholding documents requested by a duly appointed investigator in or about July-August 2006, namely, the documents relating to the fax communication of the original prescription in Rx #023942 to the College of Physicians and Surgeons of Ontario. Hearing Date: April 18, 19 and 20, 2012; and May 2, 3 and 4, 2012

Member

Summary of Allegations

Jarcew, Peter

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Jarcew committed professional misconduct in that on or about June 15, 2010 and/or August 26, 2010, while engaged in the practice of pharmacy in Toronto, Ontario, he was found guilty of sexual assault contrary to section 271 of the Criminal Code of Canada in or about October or November 2006, while engaged in the practice of pharmacy in Toronto, Ontario, he sexually assaulted a child which is a criminal offence contrary to section 271 of the Criminal Code of Canada In particular, it is alleged that he was found guilty of an offence that is relevant to his suitability to practice engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional Hearing Date: TBA

Member

Summary of Allegations

Malkin, Jerry

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Malkin committed professional misconduct in that he dispensed Schedule 1 and/or Schedule F drugs, controlled drugs, narcotics, and/or targeted substances without a prescription and/or proper authorization between the period from January 2009 to May 2011; recorded authorizations for prescriptions and/or for refills of prescriptions where no such authorization was given, and/or altered one or more written prescriptions without proper authorization; submitted false claims to third-party payors including the Ontario Drug Benefit program; wholesaled drugs without an establishment licence In particular, it is alleged that he failed to maintain a standard of practice of the profession; falsified a record relating to his practice; contravened the Pharmacy Act, 1991, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular, s. 155 of the Drug and Pharmacies Regulation Act , R.S.O. 1990, c. H-4, as amended, and/or s. 40 of Ontario Regulation 58/11 made thereunder; contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, and in particular, ss. C.01.041 and G.03.002 of the Food and Drug Regulations C.R.C., c. 870, as amended, to the Food and Drugs Act, R.S.C. 1985, c.F-27, as amended, and/or section 31 of the Narcotic Control Regulations, C.R.C., c.1041, as amended, and/or s. 51 of the Benzodiazepines and Other Targeted Substances Regulations, S.O.R./2000-271 under the Controlled Drugs and Substances Act, S.C. 1996, c. 19, as amended; and/or s. C.01A.004 of the Food and Drug Regulations C.R.C., c. 870, as amended, to the Food and Drugs Act, R.S.C. 1985, c.F-27, as amended engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional Hearing Date: TBA

Member

Summary of Allegations

Melville, Gregory

As a result of a referral by a panel of the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Melville: sexually abused a patient; failed to maintain a standard of practice of the profession; failed to keep records as required respecting his patients; falsified a record relating to his practice; signed or issued, in his professional capacity, a document that the member knew contained a false or misleading statement; engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional. In particular, these allegations relate to an alleged sexual relationship between the member and a patient, and to the alleged altering of a prescription by the member such that Inderal 80mg was prescribed but Oxycontin 80mg was dispensed. As a result of two referrals by the Executive Committee, it is alleged that Mr. Melville committed an act or acts of professional misconduct in that, while practising as a pharmacist he: failed to maintain a standard of practice of the profession; dispensed or sold drugs for an improper purpose; contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts (namely, s. 155(1) of the Drug and Pharmacies Regulation Act); contravened, while engaged in the practice of pharmacy, a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs (namely, s. 31(1) of the Narcotic Control Regulations of the Controlled Drugs and Substances Act); knowingly permitted the premises in which a pharmacy is located to be used for unlawful purposes; engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional. In particular, it is alleged that Mr. Melville provided narcotics without a prescription to people attending at Forest City pharmacy. It is further alleged that Mr. Melville committed an act or acts of professional misconduct in that, while practising as a pharmacist he: failed to maintain a standard of practice of the profession; inappropriately used a term, title or designation in respect of his practice; failed to keep records as required respecting his patients; falsified a record relating to his practice; signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement; contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts; contravened, while engaged in the practice of pharmacy, a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs; engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional. In particular, these allegations relate to an investigation into Mr. Melville's practice. As a result of a referral by the Complaints Committee, it is alleged that Mr. Melville committed an act or acts of professional misconduct in that, while practising as a pharmacist he: engaged in sexual abuse of a patient; failed to maintain a standard of practice of the profession; dispensed or sold drugs for an improper purpose; discontinued professional services that were needed, without reasonable cause; failed to keep records as required respecting the member's patients; falsified a record relating to his practice; signed or issued, in the member's professional capacity, a document that the member knew contained a false or misleading statement; contravened, while engaged in the practice of pharmacy, a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs (namely, s. 31(1), 37, 38, 39, 40(1) and 43 of the Narcotic Control Regulations of the Controlled Drugs and Substances Actand various sections of the Food and Drugs Act); engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional. In particular, these allegations relate to Mr. Melville's conduct with respect to a patient receiving methadone. As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Melville committed professional misconduct in that he possessed proceeds of property, namely money of a value not exceeding $5000, knowing the said proceeds have been derived directly or indirectly from an offence punishable by indictment, contrary to section 355(b) of the Criminal Code of Canada possessed a substance included in Schedule I of the Controlled Drugs and Substances Act, namely Oxycodone, contrary to section 4(3) of the Controlled Drugs and Substances Act trafficked in a substance included in Schedule I of the Controlled Drugs and Substances Act, namely Oxycodone, contrary to section 5(3)(a) of the Controlled Drugs and Substances Act In particular, it is alleged that on or about November 16, 2010, he was found guilty of an offence that is relevant to his suitability to practice he engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional Hearing Date: TBA

Member

Summary of Allegations

Ogowa, Godwin

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Ogowa committed professional misconduct in that he failed to complete the remedial training required by subparagraph 3(ii)(a) of the order of the Discipline Committee of the Ontario College of Pharmacists dated June 9, 2008 (the “Order”) within the time required by the Order; failed to comply with the terms of an Acknowledgement and Undertaking you entered into with the Ontario College of Pharmacists dated January 26, 2011, and in particular, failing to successfully complete the Jurisprudence Examination at the sitting held on April 20, 2011, as required by that Acknowledgement and Undertaking. In particular, it is alleged that he: contravened a term, condition or limitation imposed on his certificate of registration; engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional Hearing Date: TBA

Member

Summary of Allegations

Savji, Shaffique

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Savji committed professional misconduct in that he sexually abused a patient, L.G., in or about July 2009; dispensed a narcotic, Hydromorph Contin 3mg, to a patient, L.G., in excess of the amount prescribed and in exchange for sexual favours, in or about July 2009; and/or failed to take all reasonable steps necessary to protect narcotics at the pharmacy against loss or theft and, in particular, failed to maintain accurate inventories and other records of narcotics purchased by and dispensed at the pharmacy and/or failed to report loss or theft of narcotics, in or about 2009-2010. In particular, it is alleged that he: sexually abused a patient with inappropriate comment and/or physical contact, at the pharmacy and/or the patient’s home, in or about July 2009; failed to maintain the standards of practice of the profession; dispensed or sold drugs for an improper purpose; contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular, sections 155(1) of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-4, as amended, , and/or sections 63-64 of Regulation 551 under that Act, as amended; contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, section c.01.041(1.1) of the Food and Drug Regulations, C.R.C., c. 870, as amended, to the Food and Drugs Act, R.S.C. 1985, c.F-27, as amended, and/or sections 42 and/or 43 of the Narcotic Control Regulations, C.R.C., c.1041, as amended, under the Controlled Drugs and Substances Act, S.C. 1996, c. 19, as amended; knowingly permitted the premises in which a pharmacy was located to be used for unlawful purposes; engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional Hearing Date: March 20, 21, 27, 28, 29 and 30, 2012

Member

Summary of Allegations

Virji, Yasmin

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Virji committed professional misconduct in that she dispensed without authority; charged third party insurers and/or the patient for drugs not dispensed from on or about May 2004 to May 2008 dispensed to Dr. P.N, to Dr. P.N.’s spouse M.G-N., and to Dr. H.B., from on or about May 2004 to May 2008; dispensed and billed for large volumes of sample drugs obtained at no cost from physicians, hospitals and/or manufacturers; returned Fosrenol, returned from patient C.C., to stock to sell and/or dispense again; processed a prescription Rx165265 for Hycodan as if it was dispensed to K.L., but delivered that Hycodan to Ms. Virji’s mother; and/or offered an inducement to Dr. P.N and/or Dr. H.B. in the form of a waiver of annual deductibles and/or co-payment prescription fees for the provision of prescriptions from on or about May 2004 to May 2008. In particular, it is alleged that she: failed to maintain a standard of practice of the profession; failed to keep records as required; falsified a record relating to her practice; submitted an account or charged for services that she knew was false or misleading; charged a fee that is excessive in relation to the service provided; contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991 or the regulations under those acts, and in particular sections 155 and 156 of the Drug and Pharmacies Regulation Act; contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular sections 5 and 15(b) of the Ontario Drug Benefits Act and section 31 of the Narcotic Control Regulations; returned to stock or again sold or dispensed a drug previously sold or dispensed and delivered; offered or distributed, directly or indirectly, a gift, rebate, bonus or other inducement with respect to a prescription or prescription services; engaged in conduct or performing an act relevant to the practice of pharmacy that, having regard to all the circumstances would reasonably by regarded by members as disgraceful, dishonourable or unprofessional. Hearing Date: TBA